The California drugmaker, which has collaborations in place with Biogen, Sanofi and Eli Lilly, could be the 14th biotech to ...

Two separate research teams used base editing to make single-nucleotide changes in human embryos this month, targeting genes ...

Creative Biolabs is strengthening its lipid-based delivery portfolio with enhanced lipid nanoparticle (LNP) and liposome engineering capabilities designed to support the growing demand for RNA ...

As climate change brings longer droughts, more frequent heat waves and increasingly unpredictable growing conditions to ...

One company leads in gene-editing approvals, while the other targets surging demand in metabolic treatments. Here’s how their financials and risk profiles compare.

Developing novel ways to refine, reduce and replace the use of animals in research and enhance animal and human health.

Wealth has grown substantially over the six and a half decades since yours truly squalled his first squalls. It's also shared ...

The Europe transgenic animal model market is set for robust growth, driven by surging biotechnology investments, demand for ...

Pluristyx Inc., the leader in advanced induced pluripotent stem cell (iPSC) technologies, announces today the Initial Close of their Series A financing led by a global Fortune 500 company along with ...

Hiroshima University researchers have demonstrated a proof of concept for the mass production of genome-edited T cells that ...

We are Technlolgy based online magazine,we deliver content that is related to IT, Photography, Coding, Entertainment and ...

The firm recently advanced its first candidate into clinical testing, evaluating STX-1150 as a treatment for hypercholesterolemia.